Trial Profile
G-CSF and Erythropoetin in Survival of Patients With Decompensated Liver Disease
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Apr 2014
Price :
$35
*
At a glance
- Drugs Darbepoetin alfa (Primary) ; Granulocyte colony-stimulating factors
- Indications Liver cirrhosis
- Focus Therapeutic Use
- 01 Apr 2014 New trial record